Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Privigen for treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)
2009-017672-24Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jul 2010
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of polyvalent human immunoglobulin in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by CSL Limited. Primary endpoint: Responder rate based on INCAT score. Started Jul 2010; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2009-017672-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017672-24.